[1] Rajendran R, Sherry L, Nile CJ, et al. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013[J]. Clin Microbiol Infect, 2016, 22(1):87-93.
[2] Liu R, Chen X, Falk SP, et al. Nylon-3 polymers active against drug-resistant Candida albicans biofilms[J]. J Am Chem Soc, 2015, 137(6):2183-2186.
[3] Mahmoudabadi AZ, Zarrin M, Kiasat N, et al. Biofilm formation and susceptibility to amphotericin B and fluconazole in Candida albicans[J]. Jundishapur J Microbiol,2014, 7(7):e17105.
[4] Lammertink B, Deckers R, Storm G, et al. Duration of ultrasound-mediated enhanced plasma membrane permeability[J]. Int J Pharm, 2015, 482(1-2):92-98.
[5] Kooiman K, Vos HJ, Versluis M, et al. Acoustic behavior of microbubbles and implications for drug delivery[J]. Adv Drug Deliv Rev, 2014, 72(22):28-48.
[6] Fabienne D, Eduardo A, Joana MS, et al. PLGA-based nanoparticles:An overview of biomedical applications[J]. J Control Release,2012, 161(2):505-522.
[7] 郑璐, 余加林, 芦起,等. 白色念珠菌生物膜体外模型的建立及不同检测方法比较[J]. 中国微生态学杂志, 2010, 22(5):406-410.
[8] Nahar M, Jain NK. Preparation, Characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles[J]. Pharm Res, 2009, 26(12):2588-2599.
[9] Ramage G, Vande Walle K, Wickes BL, et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms[J]. Antimicrob Agents Chemother, 2001, 45(9):2475-2479.
[10] Pierce CG, Uppuluri P, Tristan AR, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing[J]. Nat Protoc, 2008, 3(9):1494-1500.
[11] Pande M, Dubey VK, Yadav SC, et al. A novel serine protease cryptolepain from Cryptolepis buchanani:purification and biochemical characterization[J]. J Agric Food Chem, 2006, 54(26):10141-10150.
[12] Gonalves LM, Del Bel Cury AA, Sartoratto A, et al. Effects of undecylenic acid released from denture liner on Candida biofilms[J]. J Dent Res, 2012, 91(10):985-989.
[13] Pierce CG, Vila T, Romo JA, et al. The Candida albicans biofilm matrix:composition, structure and function[J]. J Fungi (Basel), 2017, 3(1):14-22.
[14] Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans:development,architecture, and drug resistance[J]. J Bacteriol, 2001, 183(18):5385-5394.
[15] Yu H, Chen S, Cao P. Synergistic bactericidal effects and mechanisms of low intensity ultrasound and antibiotics against bacteria:areview[J]. Ultrason Sonochem, 2012,19(3):377-382.
[16] Dong Y, Su H, Jiang H, et al. Experimental study on the influence of low-frequency and low-intensity ultrasound on the permeability of the mycobacterium smegmatis cytoderm and potentiation with levofloxacin[J]. Ultrason Sonochem, 2017, 37:1-8.
[17] Van WA, Kooiman K, Harteveld M, et al. Vibrating microbubbles poking individual cells:drug transfer into cells via sonoporation[J]. J Control Release, 2006, 112(2):149-155.
[18] Wu J, Nyborg WL. Ultrasound, cavitation bubbles and their interaction with cells[J]. Adv Drug Deliv Rev, 2008, 60(10):1103-1116.
[19] Zhou Y, Pan LL, Li XH. Relationship between activity and virulence of secretory acid proteinase and extracellular phospholipase of Candida albicans from secretion of vagina in two forms[J]. Chin J Microecol, 2009, 21(5):443-446.
[20] Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis[J]. Microbiol Mol Biol Rev, 2003, 67(3):400-428. |